Figure 2.(A) The TRIM26 over survival(OS) time and disease free(DFF) survival time in the GEPIA; (B) The OS nomogram of TRIM26 for the KIRC patients; (C) The DFF nomogram of TRIM26 for the KIRC patients; (D) The correlation between TRIM26 expression and other clinical information; (E, F) The expression level of TRIEM26 in four pathological stages.
